Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe.

Hayang YangGruschen R VeldtmanBerto J BoumaWerner BudtsKoichiro NiwaFolkert MeijboomGiancarlo ScognamiglioAlexander Chima EgbeMarkus SchwerzmannCraig BrobergMarielle MorissensJonathan BuberShane TsaiIoannis PolyzoisMartijn C PostMatthias GreutmannArie Van DijkBarbara Jm MulderJamil Aboulhosn

Published in: Open heart (2019)

In this review of the largest Fontan cohort using NOACs with prospective follow-up, NOACs appear to be well tolerated and their efficacy and safety during short-term follow-up seem comparable to VKAs. Longer term data are required to confirm these promising short-term results.

Keyphrases

oral anticoagulants
atrial fibrillation
preterm infants
electronic health record
big data
gestational age
artificial intelligence
data analysis